GSK-GLP112756

Study Sponsor: GSK

Study Title

A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Multicenter Study to Determine the Efficacy and Safety of Two Dose Levels of Albiglutide Compared With Placebo in Subjects With Type 2 Diabetes Mellitus

Medicine or Vaccine (generic name)

albiglutide

Sponsor Identification Number

GLP112756

Trial Registry Identification Number(#'s)

NCT00849017

Medical Condition

Diabetes Mellitus, Type 2

Phase

Phase 3

Link to GSK Study Register

https://www.gsk-studyregister.com/en/trial-details/?id=112756

Link to study details on ClinicalTrials.gov (if available)

http://clinicaltrials.gov/show/NCT00849017

Link to study details on EudraCT (if available)

Datasets and Documents Available for this Study

Raw dataset	Annotated case report form	Dataset specifications	Protocol with any amendments
Analysis-ready dataset	Reporting and analysis plan	Clinical study report	Ready to Share

Additional information about the data and documents available for this study

This study is available in CDISC format

Date Added to this Site

March 2016